Chronic graft-versus-host disease (cGVHD) is a major limitation of successful hematopoietic
cell transplantation. The safety and efficacy of extracorporeal photopheresis (ECP) for 12 to …

The aim of our study was to assess the efficacy of extracorporeal photopheresis (ECP) in
chronic graft-versus-host disease (GVHD). Eleven patients with chronic cutaneous GVHD …

In a prior multicenter randomized controlled trial, we found that a 12-week course of
extracorporeal photopheresis (ECP) plus standard immunosuppressive therapy resulted in …

Acute and chronic graft-versus-host disease (GVHD) continue to be major limitations to
successful hematopoietic stem cell transplantation. A variety of different immunosuppressive …

Acute and chronic graft-versus-host disease (GVHD) remain major obstacles for successful
allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) …

Background The safety of extracorporeal photopheresis (ECP) in steroid-refractory chronic
graft-versus-host disease (SR-cGVHD) has been explored in multiple studies but reported …

We report 28 patients with advanced chronic graft-versus-host disease (cGVHD) treated with
extracorporeal photopheresis (ECP). All had failed conventional immunosuppressive …

We enrolled 25 patients with extensive, steroid-refractory chronic graft-versus-host disease
(cGVHD) in a prospective trial evaluating the efficacy of extracorporeal photophoresis (ECP) …

Abstract Background and Summary: Extracorporeal photopheresis (ECP) is a leukapheresis-
based procedure used in the therapy of acute and chronic graft-versus-host disease …

Despite significant advances in stem cell manipulation and post-transplant
immunosuppression, chronic graft-versus-host disease (cGVHD) remains a cause of major …